Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Immunobiology ; 224(5): 645-648, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31402150

RESUMEN

Mugwort pollen allergy is frequent in parts of Europe. As mugwort pollen contains only one major allergen, Art v 1, which harbors only one T cell epitope, we employed mugwort pollen allergy as a model to study allergen-specific T cell responses. However, after 2004, we noticed a drastic decrease in the T cell responses to Art v 1 and eventually it became almost impossible to detect allergen-specific responses at the T cell level in mugwort-allergic individuals. To explain this observation, we retrospectively investigated the local exposure to mugwort pollen and its possible correlation to the frequency and reactivity of allergen-specific T cells. The total annual pollen indices dramatically dropped after 2004 and never reached previous levels again. Local sensitization to mugwort pollen and serum IgE antibodies specific for Art v 1 remained unchanged until 2015. Our mugwort pollen model shows that specific IgE-levels are maintained for extremely long time periods in spite of a long-term reduction of natural allergen exposure to levels that are too low to boost specific T cells.


Asunto(s)
Alérgenos/inmunología , Inmunoglobulina E/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/inmunología , Linfocitos T/inmunología , Relación Dosis-Respuesta Inmunológica , Exposición a Riesgos Ambientales/efectos adversos , Epítopos de Linfocito T/inmunología , Humanos , Rinitis Alérgica Estacional/metabolismo , Especificidad del Receptor de Antígeno de Linfocitos T , Linfocitos T/metabolismo
2.
BMC Immunol ; 13: 43, 2012 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-22871092

RESUMEN

BACKGROUND: Mugwort pollen allergens represent the main cause of pollinosis in late summer. The major allergen, Art v 1, contains only one single immunodominant, solely HLA-DR-restricted T cell epitope (Art v 125-36). The frequency of HLA-DRB1*01 is highly increased in mugwort-allergic individuals and HLA-DR1 serves as restriction element for Art v 125-36. However, Art v 125-36 also binds to HLA-DR4 with high affinity and DR1-restricted Art v 125-36 -specific T cell receptors can be activated by HLA-DR4 molecules. To understand the predominance of HLA-DR1 in mugwort allergy in spite of the degeneracy in HLA/peptide-binding and TCR-recognition, we investigated the molecular background of Art v 125-36 /MHC/TCR interactions in the context of HLA-DR1 compared to -DR4. RESULTS: The majority of Art v 125-36 -specific T cell lines and clones from HLA-DR1 carrying, mugwort pollen-allergic donors reacted to synthetic and naturally processed Art v 1-peptides when presented by HLA-DR1 or HLA-DR4 expressing antigen presenting cells. However, at limiting peptide concentrations DR1 was more effective in T cell stimulation. In addition, the minimal epitope for 50% of Art v 125-36 -specific T cells was shorter for DR1 than for DR4. In vitro binding assays of Art v 125-36 mutant peptides to isolated DR1- and DR4-molecules indicated similar binding capacities and use of the same register. In silico simulation of Art v 125-36 binding to HLA-DR1 and -DR4 suggested similar binding of the central part of the peptide to either molecule, but a higher flexibility of the N- and C-terminal amino acids and detachment at the C-terminus in HLA-DR1. CONCLUSIONS: The predominance of HLA-DR1 in the response to Art v 125-36 may be explained by subtle conformation changes of the peptide bound to DR1 compared to DR4. Computer simulation supported our experimental data by demonstrating differences in peptide mobility within the HLA-DR complex that may influence TCR-binding. We suggest that the minor differences observed in vitro may be more relevant in the microenvironment in vivo, so that only presentation by HLA-DR1, but not -DR4 permits successful T cell activation.


Asunto(s)
Alérgenos/inmunología , Antígenos de Plantas/inmunología , Artemisia/química , Antígeno HLA-DR1/inmunología , Antígeno HLA-DR4/inmunología , Hipersensibilidad/inmunología , Proteínas de Plantas/inmunología , Polen/inmunología , Alérgenos/química , Secuencia de Aminoácidos , Presentación de Antígeno/inmunología , Células Presentadoras de Antígenos/inmunología , Antígenos de Plantas/química , Simulación por Computador , Epítopos de Linfocito T/química , Epítopos de Linfocito T/inmunología , Humanos , Modelos Moleculares , Datos de Secuencia Molecular , Mutación/genética , Péptidos/química , Péptidos/inmunología , Proteínas de Plantas/química , Unión Proteica/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA